Bay Bridge Capital Group, LLC Entrada Therapeutics, Inc. Transaction History
Bay Bridge Capital Group, LLC
- $139 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
103Shares Held
27.8MCall Options Held
40.3KPut Options Held
4.1K-
Baker Bros. Advisors LP New York, NY4.87MShares$38.5 Million0.93% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$34.9 Million33.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$34.7 Million60.89% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.9MShares$23 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X02.08MShares$16.5 Million0.02% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $248M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...